In vivo characterization of sustained-release formulations of human growth hormone

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 3, 1997, Pages 1431-1439

  Lee, Hye Jung ^a   Riley, Gary ^a   Johnson, Olufumni ^a   Cleland, Jeffrey L ^b   Kim, Norman ^a   Charnis, Margarita ^a   Bailey, Leone ^a   Duenas, Eileen ^b   Shahzamani, Azin ^b   Marian, Melinda ^c   Jones, Andrew J S ^b   Putney, Scott D ^a  

^a ALKERMES INC   (United States)

^b GENENTECH INC   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

MICROSPHERE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN; SOMATOMEDIN C;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; DRUG BLOOD LEVEL; GENE EXPRESSION; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RHESUS MONKEY; SEROCONVERSION; SUSTAINED RELEASE PREPARATION; TRANSGENIC MOUSE;

ANIMALS; DRUG DELIVERY SYSTEMS; FORMULARIES; GROWTH HORMONE; HUMANS; MACACA MULATTA; MALE; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 0003265331     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. ARKY, R.: (1996) Physician's Desk Reference. Medical Economics Data, Montvale, NJ, pp 2559-2562, 1996.
2. AUSTIN, P. E., DUNN, K. A., ELLY-COFIELD, K., BROWN, C. K., WOODEN, W. A. AND BRADFIELD, J. F.: (1995) Subcuticular sutures and the rate of inflammation in noncontaminated wounds Ann. Emerg. Med. 25: 328-330.
3. CLELAND, J. L.: (1995) Design and production of single-immunization vaccines using polylactide polyglycolide microsphere systems. In Vaccine Design: The Subunit and Adjuvant Approach, ed. by M. F. Powell and M.J. Newman. pp 439-462, Plenum Press, New York.
4. CLELAND, J. L.: Protein delivery from biodegradable microspheres. In Protein Delivery - Physical Systems, ed. by L. Sanders and W. Hendren, Plenum Publishing, New York, in press.
5. CLELAND, J. L.: POWELL, M. F., LIM, A., BARRON, L., BERMAN, P. W., EASTMAN, D. J., NUNBERG, J. H., WRIN, T. AND VENNARI, J. C.: Development of a single shot subunit vaccine for HIV-I. AIDS Res. Hum. Retroviruses, 10: S21-S25
6. CUNNINGHAM, B. C., MULKERRIN, M. G. AND WELLS, J. A.: Dimerization of human growth hormone by zinc Science 253: 545-548, 1991.
7. DAUGHADAY, W. F.: Growth Hormone, Insulin-Like Growth Factors and Acromegaly. In Endocrinology, ed. by L. J. DeGroot, pp. 303-329, W. B Saunders and Co., Philadelphia, 1995.
8. DAUGHADAY, W. H. AND HARVEY, S.: Growth hormone action: clinical significance. In Growth Hormone, ed. by S. Harvey, C. G. and W. H. Daughaday. pp. 475-504, CRC Press, Boca Raton, FL, 1995.
9. ELDRIDGE, J. H., STAAS, J. K., MEULBROEK, J. A., TICE, T. R. AND GILLEY, R. M.: Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antobodies. Infect. Immun. 59: 2978-2986. 1991.
10. FINKELSTEIN, J. W., ROFFWARG, H. P., BOYAR, R. M., KREAM, J. AND HELLMAN, L.: Age-related change in the twenty four hour spontaneous secretion of growth hormone. J. Clin. Endocrinol. Metab. 35: 665-670, 1972.
11. HAZRATI, A. M., LEWIS, D. H., ATKINS, T. J., STOHRER, R. C., MCPHILLIPS, C. A. AND LITTLE, J. E.: Salmonella enteritidis vaccine utilizing biodegradable microspheres Proc. Int. Symp. Control. Rel. Bioact. Mater. 20: 101-102, 1993.
12. JANEWAY, C. A. AND TRAVERS, P.: Immunobiology: The Immune System in Health and Disease, p. 2:6-2:7. Current Biology, Ltd., London, 1994.
13. JOHNSON, O. L., CLELAND, J. L., LEE, H. J., CHARNIS, M., DUENAS, E., JAWOROWICZ, W., SHEPARD, D., SHAHZAMANI, A., JONES, A. J. S. AND PUTNEY, S. D.: A month-long effect from a single injection of microencapsulated human growth hormone. Nature Med. 2: 795-799, 1996.
14. JOHNSON, O. L., JAWOROWICZ, W., CLELAND, J. L., BAILEY, L., CHARNIS, M., DUENAS, E., Wu, C., SHEPARD, D., MAGIL, S., LAST, T., JONES, A. J. S. AND PUTNEY, S. D.: The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm. Res., in press.
15. JORGENSEN, J. O., MOLLER, N., LAURITZEN, T. AND CHRISTIANSEN, J. S.: Pulsatile vs. continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices. J. Clin. Endocrinol. Metab. 70: 1616-1623, 1990.
16. LANGER, R.: New methods of drug delivery. Science 249: 1527-1533, 1990.
17. LAURSEN, T., JORGENSEN, J. O. AND CHRISTIANSEN, J. S.: (1994) Metabolic response to growth hormone (GH) administered in a pulsatile, continuous or combined pattern. Endocrinol. Metab. 1: 33-40, 1994.
18. LAURSEN, T., JORGENSEN, O. L., JAKOBSEN, G., HANSEN, B. L. AND CHRISTIANSEN, J. S.: Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients. J. Clin. Endocrinol. Metab. 80: 2410-2418, 1995.
19. LEE, H. J.: Biopharmaceutical properties and pharmacokinetics of peptide and protein drugs. In Peptide-Based Drug Design, ed. by M. Taylor and G. Amidon, pp. 69-97, American Chemical Society, Washington, D.C., 1995.
20. LI, C. H., LAHM, H. W. AND STEIN, S.: The primary structure of monkey pituitary growth hormone. Arch. Biochem. Biophys. 245: 287-291, 1986.
21. LIBERMAN, S. A., BUKAR, J., CHEN, S. A., CELNIKER, A. C., COMPTON, P. G., COOK, J., ALBU, J., PERLMAN, A. J. AND HOFFMAN, A. R.: Effects of recombinant human insulin-like growth factor I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic responses in humans. J. Clin. Endocrinol. Metab. 75: 30-36, 1992.
22. MOORE, J. A. AND WROBLEWSKI, V. J.: (1992) Pharmacokinetics and metabolism of protein hormones. In Protein Pharmacokinetics and Metabolism, ed. by B. L. Ferraiolo, pp. 93-126, Plenum Press, New York, 1992.
23. O'HAGEN, D. T., JEFFERY, H. AND DAVIS, S. S.: Poly (lactide-co-glycolide) microparticles as controlled release vaccines Proc. Int. Symp. Control. Rel. Bioact. Mater. 20: 59-60, 1993.
24. OGAWA, Y., OKADA, H., YAMAMOTA, M. AND SHIMAMOTO, T.: In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers. Chem. Pharm. Bull. 36: 2576-2581, 1988a.
25. OGAWA, Y., YAMAMOTO, M., OKADA, H., YASHIKI, T. AND SHIMAMOTO, T.: A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. Chem. Pharm. Bull. 5: 1095-1103, 1988b.
26. PEARLMAN, R. AND BEWLEY, T. A.: Stability and characterization of human growth hormone. In Stablity and Characterization of Protein and Peptide Drugs: Case Histories, Y. J. Wang and R. Pearlman, pp. 1-58, Plenum Press, New York, 1993.
27. PIHLAJAMAKI, H., BOSTMAN, O., HIRVENSALO, E., TORMALA, P. AND ROKKANEN, P.: Absorbable pins of self-reinforced poly-L-lactic acid for fixation of fractures and osteotomies J. Bone Joint Surg. 74: 853-857, 1992.
28. SCHWENDEMAN, S. P., CARDAMONE, M., BRANDON, M. R., KLIBANOV, A. AND LANGER, R: Stability of proteins and their delivery from biodegradable polymer microspheres. In Microspheres/Microparticles-Characterization and Pharmaceutical Application, ed. by S. Cohen and H. Bernstein. pp. 1-49, Marcel Dekker Inc., New York, 1996.
29. TAUBER, H., DE BOUET DU PORTAL, H., SALLERIN-CAUTE, B., ROCHICCIOLI, P. AND BASTIDE, R.: Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion vs. daily injection of recombinant human GH in GH-deficient children J. Clin. Endocrinol. Metab. 76: 1135-1139, 1993.
30. THORLACIUS-USSING, O.: Zinc in the anterior pituitary of the rat: A histochemical and analytical work. Neuroendocrinology 45: 233-242, 1987.
31. VELDHUIS, J. D. AND JOHNSON, M. L.: Cluster analysis: A simple, versatile, and robust algorithm for endocrine pulse detection. Am. J. Physiol. 250: E486-E493, 1986.
32. VISSCHER, G. E., ROBINSON, R. L. AND ARGENTIERI, G. J.: Tissue response to biodegradable injectable microcapsules. J. Biomater. Appl. 2: 118-131, 1987.
33. VISSCHER, G. E., ROBINSON, R. L., MAULDING, H. V., FONG, J. W., PEARSDN, J. E. AND ARGENTIERI, G. J.: (1985) Biodegradation of and tissue reaction to 50:50 poly (DL-lactide-co-glycolide) microcapsules. J. Biomed. Mater. Res. 19: 349-365, 1985.
34. WINDE, G., REERS, B., NOTTBERG, H., BERNS, T., MEYER, J. AND BUNTE, H.: Clinical and functional results of abdominal rectopexy with absorbable mesh-graft for treatment of complete rectal prolapse. Eur. J. Surg. 159: 301-305, 1993.